Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Cigna profit misses Wall Street target

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 01:05pm CET

Insurer Cigna Corp (>> CIGNA Corporation) posted a lower-than-expected first-quarter profit on Thursday, as earnings slipped in its segment offering disability and life coverage policies.

Insurer Cigna Corp (>> CIGNA Corporation) posted a lower-than-expected first-quarter profit on Thursday, as earnings slipped in its segment offering disability and life coverage policies.

Cigna is the latest health insurer to miss Wall Street's earnings target in the period, following Aetna Inc (>> Aetna Inc.), Coventry Health Care (>> Coventry Health Care, Inc.) and Humana Inc (>> Humana Inc.).

Cigna did raise its full-year earnings forecast.

Net income fell to $371 million, or $1.28 per share, from $413 million, or $1.51 per share, a year earlier.

Excluding special items, Cigna's earnings of $1.28 per share fell 2 cents below the analysts' average estimate, according to Thomson Reuters I/B/E/S.

Revenue jumped 25 percent to $6.79 billion, helped by the acquisition of Medicare specialist HealthSpring.

Profit in the main healthcare segment rose 6.5 percent to $262 million, helped by rising membership in its plans.

But earnings in its disability and life segment fell 16 percent to $65 million. The company cited strategic investments in its disability management programs as a factor pushing down profit.

Cigna forecast 2012 earnings of $5.20 to $5.55 per share. It previously projected $5.00 to $5.40. Analysts have been looking for $5.41.

(Reporting by Lewis Krauskopf in New York; Editing by Lisa Von Ahn)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA CORPORATION
02/24DJTrump to Meet With Insurance Executives on Repeal of Affordable Care Act -- U..
02/24 CIGNA CORP : Change in Directors or Principal Officers (form 8-K)
02/23 CIGNA : Management's Discussion and Analysis of Financial Condition and Results ..
02/23 CIGNA : CFO Thomas McCarthy to retire
02/23 CIGNA CORPORATION (NYSE : CI) Files An 8-K Departure of Directors or Certain Off..
02/23 CIGNA CORP : Change in Directors or Principal Officers, Regulation FD Disclosure..
02/23 CIGNA : Names Four Proven and Tenured Leaders to Executive Team
02/23 CIGNA CORP : Regulation FD Disclosure (form 8-K)
02/22 CIGNA : Winnebago Industries Appoints John Murabito to Its Board of Directors
02/22 CIGNA : Declares Annual Dividend
More news
Sector news : Managed Healthcare - NEC
02/24DJTrump to Meet With Insurance Executives on Repeal of Affordable Care Act -- U..
02/23 CIGNA : CFO Thomas McCarthy to retire
02/17DJAETNA : Doubles Dividend, Boosts Stock Buyback Plans
02/16DJCIGNA : Court Issues Temporary Order Keeping Cigna From Terminating Merger With ..
02/16DJANTHEM : Countersues After Cigna Ends Deal -- WSJ
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
02/24 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2016 Updat..
02/23 Cigna adds to enterprise leadership team, finance chief to retire this summer
02/22 CIGNA declares $0.04 dividend
02/21 Cigna to cover Dermacell dermal matrix; exclusive distributor Novadaq up 9% a..
02/19 Tracking David Einhorn's Portfolio - Q4 2016 Update
Advertisement
Financials ($)
Sales 2017 40 445 M
EBIT 2017 3 393 M
Net income 2017 2 345 M
Finance 2017 98,0 M
Yield 2017 0,02%
P/E ratio 2017 16,15
P/E ratio 2018 13,99
EV / Sales 2017 0,93x
EV / Sales 2018 0,87x
Capitalization 37 751 M
More Financials
Chart CIGNA CORPORATION
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 165 $
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Mark Marsters Senior Vice President-Group Operations
Thomas A. McCarthy Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION10.59%37 751
UNITEDHEALTH GROUP INC1.60%155 097
AETNA INC4.61%45 256
ANTHEM INC14.02%43 159
HUMANA INC0.48%30 952
CENTENE CORP24.90%12 147
More Results